Showing results (61-70 of 114) with videos related to
Sort By:
Pageof 12
Experimental Hematology & Oncology|September 22, 2023
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma modelsWing Keung Chan, Jessica Williams, Kinnari Sorathia, et al.Blood Advances|February 20, 2020
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaRichard T Maziarz, Edmund K Waller, Ulrich Jaeger, et al.British Journal of Haematology|July 1, 2025
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphomaJohn Sharp, Qiuhong Zhao, Timothy J Voorhees, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2019
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin LymphomaSara Singer, Robert Dean, Qiuhong Zhao, et al.Bone Marrow Transplantation|February 6, 2019
BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomasSara Singer, Nidhi Sharma, Robert Dean, et al.Blood Advances|October 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph Pidala, Jongphil Kim, Denise Kalos, et al.Journal of Clinical Medicine|July 2, 2021
Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical TransplantationNidhi Sharma, Muhammad Salman Faisal, Qiuhong Zhao, et al.Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.Journal of the American Heart Association|September 19, 2025
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell TransplantationCooper Quartermaine, Zach Braunstein, Adnan Shaaban, et al.Blood Advances|February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphomaGeoffrey Shouse, Andy Kaempf, Max J Gordon, et al.Pageof 12